| __timestamp | Evotec SE | Travere Therapeutics, Inc. |
|---|---|---|
| Wednesday, January 1, 2014 | 17990000 | 59644696 |
| Thursday, January 1, 2015 | 25166000 | 79541000 |
| Friday, January 1, 2016 | 27013000 | 98015000 |
| Sunday, January 1, 2017 | 42383000 | 103958000 |
| Monday, January 1, 2018 | 57012000 | 103654000 |
| Tuesday, January 1, 2019 | 66546000 | 128951000 |
| Wednesday, January 1, 2020 | 77238000 | 135799000 |
| Friday, January 1, 2021 | 105445000 | 149883000 |
| Saturday, January 1, 2022 | 156190000 | 220206000 |
| Sunday, January 1, 2023 | 169610000 | 265542000 |
Cracking the code
In the ever-evolving landscape of biotechnology, operational efficiency is paramount. Over the past decade, Travere Therapeutics, Inc. and Evotec SE have demonstrated contrasting trajectories in their Selling, General, and Administrative (SG&A) expenses. From 2014 to 2023, Travere Therapeutics saw a staggering 345% increase in SG&A costs, peaking at approximately $266 million in 2023. In contrast, Evotec SE's expenses grew by 843%, reaching around $170 million in the same year. This divergence highlights Travere's aggressive expansion strategy compared to Evotec's more measured approach. The data underscores the importance of strategic financial management in sustaining growth and competitiveness in the biotech sector. As these companies continue to innovate, their financial strategies will be crucial in shaping their future trajectories.
Breaking Down SG&A Expenses: Pfizer Inc. vs Evotec SE
GSK plc vs Evotec SE: SG&A Expense Trends
Genmab A/S vs Travere Therapeutics, Inc.: SG&A Expense Trends
Selling, General, and Administrative Costs: Bio-Techne Corporation vs Evotec SE
Who Optimizes SG&A Costs Better? Alpine Immune Sciences, Inc. or Travere Therapeutics, Inc.
Cost Management Insights: SG&A Expenses for Alpine Immune Sciences, Inc. and Evotec SE
Who Optimizes SG&A Costs Better? ADMA Biologics, Inc. or Evotec SE
Amneal Pharmaceuticals, Inc. vs Travere Therapeutics, Inc.: SG&A Expense Trends
Operational Costs Compared: SG&A Analysis of PTC Therapeutics, Inc. and Evotec SE
ACADIA Pharmaceuticals Inc. or Evotec SE: Who Manages SG&A Costs Better?
Selling, General, and Administrative Costs: Amicus Therapeutics, Inc. vs Travere Therapeutics, Inc.
Selling, General, and Administrative Costs: Ligand Pharmaceuticals Incorporated vs Travere Therapeutics, Inc.